Modification to Outback Catheter
Lumend
FDA Clearance Information
The modification to the Outback Catheter was cleared through the FDA 510k pathway on January 11, 2002. Manufactured by Lumend, it is classified as a Class 2 device under product code DQY.
What It Is
FDA-Cleared Indications
- Use as a percutaneous catheter as described in the FDA-cleared labeling.
- The FDA record identifies the device under product code DQY, Catheter, Percutaneous, 21 CFR 870.1250.
Clinical Applications
- Percutaneous catheter-based vascular procedures within the limits of the cleared labeling.
- Use with compatible endovascular equipment when specified by the device instructions for use.
Reported off-label uses
- Re-entry or crossing of difficult peripheral vascular occlusions has been reported for Outback-type catheter systems, but this should not be assumed to apply to this modified device without reviewing its labeling.
- Use during selected venous recanalization or venous-stenting procedures may occur in practice, but the specific indication should be confirmed from the device instructions for use.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Confirm the exact catheter model, dimensions, guidewire requirements, and compatible sheath size in the current instructions for use.
- The available FDA summary does not specify MRI safety. Do not assume the device is MR Safe or MR Conditional without manufacturer documentation.
- Use requires fluoroscopic or other appropriate imaging guidance and trained endovascular personnel.
- Review contraindications, warnings, vessel-size limitations, and compatibility requirements before use.
- The catheter is a single-use endovascular device; it is not intended to remain implanted after the procedure.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for modification to Outback Catheter?
The device is indicated for use in venous stenting procedures, particularly in peripheral artery interventions above and below the knee.
What outcomes have been reported in clinical studies?
The studies provided do not detail specific outcomes, highlighting a gap in the current evidence.
What complications have been reported?
Safety data from the studies is limited, with no specific complications detailed in the provided evidence.